REVIEW
Published on 17 Dec 2024
Exosomes in esophageal cancer: a promising frontier for liquid biopsy in diagnosis and therapeutic monitoring
doi 10.3389/fphar.2024.1459938
- 725 views
- 1 citation
- Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
- Research Topics
- Novel Biomarkers in Solid Tumors and Related Medicine Therapy
Novel Biomarkers in Solid Tumors and Related Medicine Therapy
5,409
Total downloads
17k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 15 Oct 2024
Profiling of the serum MiRNAome in pediatric egyptian patients with wilms tumor
doi 10.3389/fmolb.2024.1453562
- 1,123 views
ORIGINAL RESEARCH
Published on 25 Sep 2024
Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma in vivo
doi 10.3389/fphar.2024.1468920
- 908 views
ORIGINAL RESEARCH
Published on 29 Aug 2024
Investigating the therapeutic potential of hesperidin targeting CRISP2 in intervertebral disc degeneration and cancer risk mitigation
doi 10.3389/fphar.2024.1447152
- 1,302 views
ORIGINAL RESEARCH
Published on 20 Aug 2024
The role of GZMA as a target of cysteine and biomarker in Alzheimer’s disease, pelvic organ prolapse, and tumor progression
doi 10.3389/fphar.2024.1447605
- 1,244 views
SYSTEMATIC REVIEW
Published on 15 Aug 2024
Diagnostic lncRNA high expression for liver patients prognosis and medication guidance: a systematic review and meta-analysis
doi 10.3389/fphar.2024.1462512
- 610 views
ORIGINAL RESEARCH
Published on 02 Aug 2024
Oncoproteins E6 and E7 upregulate topoisomerase I to activate the cGAS-PD-L1 pathway in cervical cancer development
doi 10.3389/fphar.2024.1450875
- 1,157 views
- 5 citations
ORIGINAL RESEARCH
Published on 05 Jul 2024
PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses
doi 10.3389/fphar.2024.1418560
- 3,086 views
- 1 citation
ORIGINAL RESEARCH
Published on 14 Jun 2024
STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYC
doi 10.3389/fmolb.2024.1419072
- 897 views
- 2 citations
ORIGINAL RESEARCH
Published on 11 Jun 2024
The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation
doi 10.3389/fimmu.2024.1421778
- 1,264 views
Published in
Frontiers in Molecular Biosciences
Molecular Diagnostics and Therapeutics
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore